Full Name
Cynthia Ma, MD, PhD
Speaker Bio
Cynthia X. Ma, MD, PhD is a Professor Medicine in the Division of Oncology and the Clinical Director of the Breast Cancer Program in the Division of Oncology at Washington University School of Medicine. Dr. Ma is a physician scientist with a research focus in breast cancer biomarker and targeted therapeutics development.
Dr. Ma is the study chair for the ongoing phase III Alliance trial A011106 (ALTERNATE trial) to validate neoadjuvant biomarker endpoint as surrogate markers of long-term outcome and to investigate endocrine resistance mechanisms for estrogen receptor positive breast cancer. Her laboratory has focused on biomarkers and resistance mechanisms for agents that target cell cycle and PI3K pathway through analysis of clinical specimens and preclinical studies using breast cancer cell lines and patient-derived xenograft models.
Dr. Ma is the study chair for the ongoing phase III Alliance trial A011106 (ALTERNATE trial) to validate neoadjuvant biomarker endpoint as surrogate markers of long-term outcome and to investigate endocrine resistance mechanisms for estrogen receptor positive breast cancer. Her laboratory has focused on biomarkers and resistance mechanisms for agents that target cell cycle and PI3K pathway through analysis of clinical specimens and preclinical studies using breast cancer cell lines and patient-derived xenograft models.
Speaking At
